Gastroenterology and Immune-Mediated Disease Research

At East Tallinn Central Hospital, the Gastroenterology Centre is involved in studies across digestive system diseases and immune system diseases, with a focus on ulcerative colitis and rheumatoid arthritis. This work is aimed at evaluating new treatment options and understanding how well they control symptoms and support long-term disease management.

  • Clinical research in ulcerative colitis is exploring whether new therapies can improve remission and disease control.
  • Studies in rheumatoid arthritis are assessing treatment effectiveness, safety, and relief of joint inflammation.
  • The site contributes to research on inflammatory conditions that affect both the gut and the immune system.

These trials help clarify how emerging therapies may improve day-to-day outcomes for people living with chronic inflammatory disease.

Musculoskeletal Health and Bone Disease Trials

The site also supports research in musculoskeletal diseases, especially post-menopausal osteoporosis and rheumatoid arthritis. The studies are designed to compare treatment effects, strengthen bone health, and assess whether new options can deliver similar benefits to established therapies.

  • Post-menopausal osteoporosis research is focused on improving bone density and reducing bone loss.
  • Rheumatoid arthritis studies evaluate symptom control and the ability to slow disease progression.
  • These trials examine how well investigational treatments perform against current standards of care.

This area of research is important for patients living with chronic joint disease and age-related bone weakening.

Oncology Clinical Trials

Neoplasm research at the hospital includes studies in unresectable or metastatic melanoma. The main goal is to test whether newer cancer therapies can improve outcomes for patients with advanced disease while maintaining acceptable safety and tolerability.

  • Melanoma trials are evaluating treatment effectiveness in advanced, hard-to-treat cancer.
  • The research focuses on comparing new options with established immunotherapy approaches.
  • These studies aim to expand treatment choices for patients with limited alternatives.

Work in this oncology area reflects the site’s involvement in both chronic disease and cancer research.